Global Cholesterol Lowering Drugs Market Size worth US$ 64.62 billion by 2030 | Growth Plus Reports

view original post

GlobeNewswire

DSV, 1018 – SHARE BUYBACK IN DSV A/S

Company Announcement No. 1018 On 2 February 2023, we initiated a share buyback programme, as described in Company Announcement No. 1013. According to the programme, the company will in the period from 2 February 2023 until 26 April 2023 purchase own shares up to a maximum value of DKK 2,500 million, and no more than 4,000,000 shares, corresponding to 1.83% of the share capital at commencement of the programme. The programme has been implemented in accordance with Regulation No. 596/2014 of the E